We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Fed Circ. Sets Product-By-Process Patent Restrictions

Law360 (May 18, 2009, 12:00 AM EDT) -- In two cases over a patent related to Abbott Laboratories' bacterial infection drug Omnicef, an appeals court has ruled that defining a product in a patent by the process through which...
To view the full article, register now.